Myasthenia gravis (MG) can cause weakness of the eyelids and extraocular muscles in up to 90% of patients; approximately half of such patients will present with isolated ocular symptoms (ie, ptosis and/or diplopia only).
1 The diagnosis of ocular MG (OMG) is not always clinically evident, as the pattern of deficits can mimic a cranial nerve palsy, internuclear ophthalmoplegia, or thyroid eye disease. In addition, some patients with suspected OMG do not respond to first-line treatment with pyrdiostigmine and are candidates for immunosuppressive therapy, which carries a risk of harmful adverse effects.
1-3 For these reasons, ancillary testing is often used to confirm the diagnosis of OMG.